Literature DB >> 19917491

A tail of Tetherin: how pandemic HIV-1 conquered the world.

Ravindra K Gupta1, Greg J Towers.   

Abstract

The study of successful versus failed zoonotic infections may provide important clues of how viral infection is naturally prevented. In this issue of Cell Host & Microbe, a collaborative group led by Frank Kirchhoff uncovers an important piece of the pandemic HIV-1 puzzle.

Entities:  

Year:  2009        PMID： 19917491      PMCID： PMC3556580          DOI： 10.1016/j.chom.2009.11.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  9 in total

1.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

Authors:  Stuart J D Neil; Trinity Zang; Paul D Bieniasz
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

2.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

3.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

4.  Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.

Authors:  Anna Le Tortorec; Stuart J D Neil
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

5.  Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

Authors:  Matthew W McNatt; Trinity Zang; Theodora Hatziioannou; Mackenzie Bartlett; Ismael Ben Fofana; Welkin E Johnson; Stuart J D Neil; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823

6.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

7.  Nef proteins from simian immunodeficiency viruses are tetherin antagonists.

Authors:  Fengwen Zhang; Sam J Wilson; Wilmina C Landford; Beatriz Virgen; Devon Gregory; Marc C Johnson; Jan Munch; Frank Kirchhoff; Paul D Bieniasz; Theodora Hatziioannou
Journal:  Cell Host Microbe       Date:  2009-06-04       Impact factor: 21.023

8.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

9.  Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

Authors:  Ravindra K Gupta; Petra Mlcochova; Annegret Pelchen-Matthews; Sarah J Petit; Giada Mattiuzzo; Deenan Pillay; Yasuhiro Takeuchi; Mark Marsh; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205
  9 in total
  13 in total

Review 1.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

2.  Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.

Authors:  Isabelle Dietrich; Elizabeth L McMonagle; Sarah J Petit; Swetha Vijayakrishnan; Nicola Logan; Chi N Chan; Greg J Towers; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

4.  Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.

Authors:  Silvia F Kluge; Katharina Mack; Shilpa S Iyer; François M Pujol; Anke Heigele; Gerald H Learn; Shariq M Usmani; Daniel Sauter; Simone Joas; Dominik Hotter; Frederic Bibollet-Ruche; Lindsey J Plenderleith; Martine Peeters; Matthias Geyer; Paul M Sharp; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

Review 5.  Origins of HIV and the AIDS pandemic.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

6.  Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.

Authors:  Yingying Li; Jean-Bosco Ndjango; Gerald H Learn; Miguel A Ramirez; Brandon F Keele; Frederic Bibollet-Ruche; Weimin Liu; Juliet L Easlick; Julie M Decker; Rebecca S Rudicell; Bila-Isia Inogwabini; Steve Ahuka-Mundeke; Fabian H Leendertz; Vernon Reynolds; Martin N Muller; Rebecca L Chancellor; Aaron S Rundus; Nicole Simmons; Michael Worobey; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

7.  Restriction of Retroviral Replication by Tetherin/BST-2.

Authors:  Jason Hammonds; Jaang-Jiun Wang; Paul Spearman
Journal:  Mol Biol Int       Date:  2012-07-02

8.  Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.

Authors:  Sarah J Petit; Caroline Blondeau; Greg J Towers
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

9.  The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function.

Authors:  Silvia F Kluge; Daniel Sauter; Michael Vogl; Martine Peeters; Yingying Li; Frederic Bibollet-Ruche; Beatrice H Hahn; Frank Kirchhoff
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

10.  Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.

Authors:  Daniel Sauter; Daniel Unterweger; Michael Vogl; Shariq M Usmani; Anke Heigele; Silvia F Kluge; Elisabeth Hermkes; Markus Moll; Edward Barker; Martine Peeters; Gerald H Learn; Frederic Bibollet-Ruche; Joëlle V Fritz; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.